Case Name: Wayland EZEB v. SANDOZ PHARMACEUTICALS, et al.
Court: Louisiana Supreme Court
Jurisdiction: Louisiana
Decision Date: 2016-06-03
Citations: 192 So. 3d 756
Docket Number: No. 2016-CC-0886
Parties: Wayland EZEB v. SANDOZ PHARMACEUTICALS, et al.
Judges: JOHNSON, C.J., KNOLL and CLARK, JJ., would deny.
Reporter: Southern Reporter, Third Series
Volume: 192
Pages: 756–756

Head Matter:
Wayland EZEB v. SANDOZ PHARMACEUTICALS, et al.
No. 2016-CC-0886.
Supreme Court of Louisiana.
June 3, 2016.

Opinion:
In re Novartis Pharmaceuticals Corporation, successor by merger to Sandoz Pharmaceuticals Corporation; — Defendant; Applying For Writ of Certiorari and/or Review, Parish of Orleans, Civil District Court Div. A, No. 92-20622; to the Court of Appeal, Fourth Circuit, No. 2016-C-0428.
Granted. Under the unique facts presented, the district court did not abuse its great discretion in granting relator's motion. Accordingly, the judgment of the court of appeal is reversed, and the judgment of the district court is reinstated.
JOHNSON, C.J., KNOLL and CLARK, JJ., would deny.